| Unadjusted models | Adjusted models* | ||
---|---|---|---|---|
Severity outcomes | OR (95% CI) | P value | OR (95% CI) | P value |
1) Intensive care use | ||||
 All profiles | ||||
  Haemophilus-dominant profile | 6.20 (2.38–18.28) | < 0.001 | 6.43 (2.25–20.51) | < 0.001 |
  Moraxella-dominant profile | Reference |  | Reference |  |
  Staphylococcus-dominant profile | 2.54 (1.14–6.78) | 0.04 | 2.17 (0.93–5.98) | 0.10 |
  Corynebacterium-dominant profile | 3.75 (1.52–10.62) | 0.007 | 4.15 (1.59–12.37) | 0.005 |
  Enterobacter-dominant profile | 4.51 (1.68–13.53) | 0.004 | 4.84 (1.67–15.46) | 0.004 |
  Mixed profile | 3.86 (1.59–10.85) | 0.005 | 3.37 (1.29–9.99) | 0.02 |
 Haemophilus vs. all others | ||||
  Combined non-Haemophilus profiles | Reference |  | Reference |  |
  Haemophilus-dominant profile | 2.21 (1.17–3.99) | 0.01 | 2.48 (1.19–5.03) | 0.01 |
 Moraxella vs. All others | ||||
  Combined non-Moraxella profiles | Reference |  | Reference |  |
  Moraxella-dominant profile | 0.30 (0.11–0.64) | 0.01 | 0.32 (0.12–0.72) | 0.01 |
2) Hospital length of stay ≥ 5 days | ||||
 All profiles | ||||
  Haemophilus-dominant profile | 3.57 (1.52–8.77) | 0.004 | 4.31 (1.73–11.11) | 0.002 |
  Moraxella-dominant profile | Reference |  | Reference |  |
  Staphylococcus-dominant profile | 1.43 (0.72–3.09) | 0.33 | 1.24 (0.61–2.75) | 0.57 |
  Corynebacterium-dominant profile | 2.03 (0.91–4.76) | 0.09 | 2.02 (0.86–4.95) | 0.11 |
  Enterobacter-dominant profile | 1.45 (0.52–3.89) | 0.46 | 1.37 (0.48–3.83) | 0.55 |
  Mixed profile | 1.75 (0.78–4.11) | 0.18 | 1.72 (0.73–4.20) | 0.22 |